Although altered expression profiles of DNAM-1, CRTAM, Tactile and TIGIT are reported in peripheral blood samples of patients diagnosed with MS, RA, SSc, psoriasis, etc., a correlation with disease severity and progression in time is often lacking. This evidence concerns the gene CRTAM and myeloid sarcoma.